Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Vos, Evert
Published human trials report minimal adverse events at doses ranging from 50mg to 100mg daily over 12 weeks, with the most common findings being mild gastrointestinal discomfort (812% of participants) and transient headache (57%)
This is the most powerful option available at our Chicago locations
That is the evidence gap, stated plainly: the mechanism is well-motivated and the preclinical signal is consistent, but no human study has confirmed that any of it translates to people, at any dose, by any route
Ideal candidates typically include: Body composition goals: Individuals focused on reducing body fat percentage while preserving lean muscle mass, those who have reached plateaus with diet and exercise alone, patients seeking metabolically selective approaches without growth hormones broader effects, or individuals interested in targeted fat reduction (particularly abdominal/visceral fat)
